Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review

Table 2 Concomitant treatments in the Kumamoto study

	MIT group	CIT group
	(multiple insulin injection) (N=55)	(Conventional insulin therapy group) (N=55)
Statins	6	6
Fibrates	2	3
Aspirin	0	0
Antiplatelet therapy	1	2
ACEIs	7	10
ARBs	0	0

ISSN: 1471-2288